.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
intervention: an evaluation of prasugrel or ticagrelor versus clopidogrel. J
Cardiovasc Pharmacol Ther 2017;22:546 551.
1090. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L,
Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P,
Collins R, Camm AJ, Heidbuchel H, ESC Scientific Document Group. The
2018 European Heart Rhythm Association Practical Guide on the use of non-
vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur
Heart J 2018;39:13301393.
1091. Pikija S, Sztriha LK, Sebastian Mutzenbach J, Golaszewski SM, Sellner J.
Idarucizumab in dabigatran-treated patients with acute ischemic stroke receiv-
ing alteplase: a systematic review of the available evidence. CNS Drugs
2017;31:747757.
1092. Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ. Risk of early death
and recurrent stroke and effect of heparin in 3169 patients with acute ische-
mic stroke and atrial fibrillation in the International Stroke Trial. Stroke
2001;32:23332337.
1093. Hart RG, Coull BM, Hart D. Early recurrent embolism associated with non-
valvular atrial fibrillation: a retrospective study. Stroke 1983;14:688693.
1094. Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight hepa-
rin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation:
a double-blind randomised study. HAEST Study Group. Heparin in Acute
Embolic Stroke Trial. Lancet 2000;355:12051210.
1095. Paciaroni M, Agnelli G, Micheli S, Caso V. Efficacy and safety of anticoagulant
treatment in acute cardioembolic stroke: a meta-analysis of randomized con-
trolled trials. Stroke 2007;38:423430.
1096. von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD,
Treurniet KM, Majoie CB, Marquering HA, Mazya MV, San Roman L, Saver JL,
Strbian D, Whiteley W, Hacke W. The Heidelberg Bleeding Classification:
classification of bleeding events after ischemicstroke and reperfusion therapy.
Stroke 2015;46:29812986.
1097. Paciaroni M, Agnelli G, Corea F, Ageno W, Alberti A, Lanari A, Caso V,
Micheli S, Bertolani L, Venti M, Palmerini F, Biagini S, Comi G, Previdi P,
Silvestrelli G. Early hemorrhagic transformation of brain infarction: rate, pre-
dictive factors, and influence on clinical outcome: results of a prospective mul-
ticenter study. Stroke 2008;39:22492256.
1098. Kablau M, Kreisel SH, Sauer T, Binder J, Szabo K, Hennerici MG, Kern R.
Predictors and early outcome of hemorrhagic transformation after acute
ischemic stroke. Cerebrovasc Dis 2011;32:334341.
1099. Seiffge DJ, Werring DJ, Paciaroni M, Dawson J, Warach S, Milling TJ, Engelter
ST, Fischer U, Norrving B. Timing of anticoagulation after recent ischaemic
stroke in patients with atrial fibrillation. Lancet Neurol 2019;18:117126.
1100. Paciaroni M, Agnelli G, Falocci N, Tsivgoulis G, Vadikolias K, Liantinioti C,
Chondrogianni M, Bovi P, Carletti M, Cappellari M, Zedde M, Ntaios G,
Karagkiozi E, Athanasakis G, Makaritsis K, Silvestrelli G, Lanari A, Ciccone A,
Putaala J, Tomppo L, Tatlisumak T, Abdul-Rahim AH, Lees KR, Alberti A,
Venti M, Acciarresi M, D’Amore C, Becattini C, Mosconi MG, Cimini LA,
Soloperto R, Masotti L, Vannucchi V, Lorenzini G, Tassi R, Guideri F, Acampa
M, Martini G, Sohn SI, Marcheselli S, Mumoli N, De Lodovici ML, Bono G,
Furie KL, Tadi P, Yaghi S, Toni D, Letteri F, Tassinari T, Kargiotis O, Lotti EM,
Flomin Y, Mancuso M, Maccarrone M, Giannini N, Bandini F, Pezzini A, Poli L,
Padovani A, Scoditti U, Denti L, Consoli D, Galati F, Sacco S, Carolei A, Tiseo
C, Gourbali V, Orlandi G, Giuntini M, Chiti A, Giorli E, Gialdini G, Corea F,
Ageno W, Bellesini M, Colombo G, Monaco S, Maimone Baronello M,
Karapanayiotides T, Caso V. Early Recurrence and Major Bleeding in Patients
With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-
Vitamin-K Oral Anticoagulants (RAF-NOACs) study. J Am Heart Assoc 2017;6.
1101. Seiffge DJ, Traenka C, Polymeris A, Hert L, Peters N, Lyrer P, Engelter ST,
Bonati LH, De Marchis GM. Early start of DOAC after ischemic stroke: risk of
intracranial hemorrhage and recurrent events. Neurology 2016;87:18561862.
1102. Arihiro S, Todo K, Koga M, Furui E, Kinoshita N, Kimura K, Yamagami H,
Terasaki T, Yoshimura S, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S,
Okada Y, Nagakane Y, Kameda T, Hasegawa Y, Shibuya S, Ito Y, Nakashima T,
Takamatsu K, Nishiyama K, Matsuki T, Homma K, Takasugi J, Tokunaga K, Sato
S, Kario K, Kitazono T, Toyoda K; SAMURAI Study Investigators. Three-month
risk-benefit profile of anticoagulation after stroke with atrial fibrillation: the
SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study. Int J Stroke
2016;11:565574.
1103. Hong KS, Kwon SU, Lee SH, Lee JS, Kim YJ, Song TJ, Kim YD, Park MS, Kim
EG, Cha JK, Sung SM, Yoon BW, Bang OY, Seo WK, Hwang YH, Ahn SH,
Kang DW, Kang HG, Yu KH, Phase 2 exploratory clinical study to assess the
effects of xarelto versus warfarin on ischemia B, hospital stay in acute cerebral
infarction patients with non-valvular atrial fibrillation study G. Rivaroxaban vs
warfarin sodium in the ultra-early period after atrial fibrillation-related mild
ischemic stroke: a randomized clinical trial. JAMA Neurol 2017;74:12061215.
1104. Ntaios G, Papavasileiou V, Diener HC, Makaritsis K, Michel P. Nonvitamin-K-
antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation
and previous stroke or transient ischemic attack: an updated systematic review
and meta-analysis of randomized controlled trials. Int J Stroke
2017;12:589596.
1105. Gonzalez ME, Klein FR, Riccio PM, Cassara FP, Munoz Giacomelli F, Racosta
JM, Roberts ES, Sposato, LA. Atrial fibrillation detected after acute ischemic
stroke: evidence supporting the neurogenic hypothesis. J Stroke Cerebrovasc Dis
2013;22:e486491.
1106. Sposato LA, Cerasuolo JO, Cipriano LE, Fang J, Fridman S, Paquet M, Saposnik
G. Atrial fibrillation detected after stroke is related to a low risk of ischemic
stroke recurrence. Neurology 2018;90:e924e931.
1107. Steinberg BA, Shrader P, Pieper K, Thomas L, Allen LA, Ansell J, Chan PS,
Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Kowey PR, Mahaffey KW,
NaccarelliGV,ReiffelJA,Singer,DE,PetersonED,Piccini,JP;OutcomesRegistry
for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) II Investigators.
Frequency and outcomes of reduced dose non-vitamin K antagonist anticoagulants:
results from ORBIT-AF II (the Outcomes Registry for Better Informed Treatment
of Atrial Fibrillation II). J Am Heart Assoc 2018;7:e007633.
1108. Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD,
Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik
R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J,
Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ,
Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, Endres M,
Muir KW, Bornstein N, Ozturk S, O’Donnell MJ, De Vries Basson MM, Pare
G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh
A, Benavente OR, Joyner C, Themeles E, Connolly SJ; NAVIGATE ESUS
Investigators. Rivaroxaban for Stroke Prevention after Embolic Stroke of
Undetermined Source. N Engl J Med 2018;378:21912201.
1109. Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S,
Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M,
Donnan G, Ferro JM, Grond M, Kallmunzer B, Krupinski J, Lee BC, Lemmens
R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-
SPECT ESUS Steering Committee Investigators. Dabigatran for prevention of
stroke after embolic stroke of undetermined source. N Engl J Med
2019;380:19061917.
1110. Healey JS, Gladstone DJ, Swaminathan B, Eckstein J, Mundl H, Epstein AE,
Haeusler KG, Mikulik R, Kasner SE, Toni D, Arauz A, Ntaios G, Hankey GJ,
Perera K, Pagola J, Shuaib A, Lutsep H, Yang X, Uchiyama S, Endres M, Coutts
SB, Karlinski M, Czlonkowska A, Molina CA, Santo G, Berkowitz SD, Hart RG,
Connolly SJ. Recurrent stroke with rivaroxaban compared with aspirin accord-
ing to predictors of atrial fibrillation: secondary analysis of the NAVIGATE
ESUS randomized clinical trial. JAMA Neurol
2019.
1111. Geisler T, Poli S, Meisner C, Schreieck J, Zuern CS, Nagele T, Brachmann J,
Jung W, Gahn G, Schmid E, Baezner H, Keller T, Petzold GC, Schrickel JW,
Liman J, Wachter R, Schon F, Schabet M, Lindner A, Ludolph AC, Kimmig H,
Jander S, Schlegel U, Gawaz M, Ziemann U. Apixaban for treatment of embolic
stroke of undetermined source (ATTICUS randomized trial): rationale and
study design. Int J Stroke 2017;12:985990.
1112. Li Y-G, Bisson A, Bodin A, Herbert J, Grammatico-Guillon L, Joung B, Wang
Y-T, Lip GYH, Fauchier L. C2HEST score and prediction of incident atrial
fibrillation in poststroke patients: a French nationwide study. J Am Heart Assoc
2019;8:e012546.
1113. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H,
O’Donnell M, Laupacis A, Cote R, Sharma M, Blakely JA, Shuaib A, Hachinski
V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S,
Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K,
Aviv R, Kapral MK, Mamdani M; EMBRACE Investigators and Coordinators.
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med
2014;370:24672477.
1114. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA,
Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J; CRYSTAL
AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J
Med 2014;370:24782486.
1115. Wachter R, Groschel K, Gelbrich G, Hamann GF, Kermer P, Liman J, Seegers
J, Wasser K, Schulte A, Jurries F, Messerschmid A, Behnke N, Groschel S,
Uphaus T, Grings A, Ibis T, Klimpe S, Wagner-Heck M, Arnold M, Protsenko
E, Heuschmann PU, Conen D, Weber-Kruger M; Find-AF(randomised)
Investigators and Coordinators. Holter-electrocardiogram-monitoring in
patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label
randomised controlled trial. Lancet Neurol 2017;16:282290.
1116. Grond M, Jauss M, Hamann G, Stark E, Veltkamp R, Nabavi D, Horn M,
Weimar C, Kohrmann M, Wachter R, Rosin L, Kirchhof P. Improved detection
of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic
stroke: a prospective multicenter cohort study. Stroke 2013;44:33573364.
1117. Kishore A, Vail A, Majid A, Dawson J, Lees KR, Tyrrell PJ, Smith CJ. Detection
of atrial fibrillation after ischemic stroke or transient ischemic attack: a system-
atic review and meta-analysis. Stroke 2014;45:520526.
ESC Guidelines 115